HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Background: Breast cancer in very young women (BCVY) defined as <35 years old, presents with different molecular biology than in older patients. High HDAC5 expression has been associated with poor prognosis in breast cancer (BC) tissue. We aimed to analyze HDAC5 expression in BCVY and older patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072585/
https://ncbi.nlm.nih.gov/pubmed/32050699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020412
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados